Patients with systemic sclerosis and low CD4 numbers after autologous stem cell transplantation have...
Patients with systemic sclerosis and low CD4 numbers after autologous stem cell transplantation have a favorable outcome
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Treatment with high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation (aHSCT) is an intensive treatment option for patients with severe forms of systemic sclerosis (SSc). Even though associated with a high treatment related mortality, the results in this high-risk population are generally favourable. The knowledge on...
Alternative Titles
Full title
Patients with systemic sclerosis and low CD4 numbers after autologous stem cell transplantation have a favorable outcome
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_607d4df2ca714005b7a728ad10cd4270
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_607d4df2ca714005b7a728ad10cd4270
Other Identifiers
ISSN
1478-6362,1478-6354
E-ISSN
1478-6362
DOI
10.1186/s13075-024-03300-1
